Skip to content
About Us
About Epigral
Our Core Ethos
Board of Directors
Our Journey
R&D
Corporate Brochure
Products
Chlor Alkali
Chloromethanes
Hydrogen Peroxide
Epichlorohydrin
CPVC
Chlorotoluenes Value Chain
Product Flow Chart
Sustainability
Certifications
Environment Health and Safety
Corporate Social Responsibility
Investors
Results
Information on Shareholders
Financial Snapshot and Graphs
Shareholding Pattern
Rating Rationale
Governance, Policies & Compliances
FAQs
Key Contacts
Media
Digital Domain
Print Chronicles
Television Broadcasts
Careers
Contact us
About Us
About Epigral
Our Core Ethos
Board of Directors
Our Journey
R&D
Corporate Brochure
Products
Chlor Alkali
Chloromethanes
Hydrogen Peroxide
Epichlorohydrin
CPVC
Chlorotoluenes Value Chain
Product Flow Chart
Sustainability
Certifications
Environment Health and Safety
Corporate Social Responsibility
Investors
Results
Information on Shareholders
Financial Snapshot and Graphs
Shareholding Pattern
Rating Rationale
Governance, Policies & Compliances
FAQs
Key Contacts
Media
Digital Domain
Print Chronicles
Television Broadcasts
Careers
Contact us
About Us
About Epigral
Our Core Ethos
Board of Directors
Our Journey
R&D
Corporate Brochure
Products
Chlor Alkali
Chloromethanes
Hydrogen Peroxide
Epichlorohydrin
CPVC
Chlorotoluenes Value Chain
Product Flow Chart
Sustainability
Certifications
Environment Health and Safety
Corporate Social Responsibility
Investors
Results
Information on Shareholders
Financial Snapshot and Graphs
Shareholding Pattern
Rating Rationale
Governance, Policies & Compliances
FAQs
Key Contacts
Media
Digital Domain
Print Chronicles
Television Broadcasts
Careers
Contact us
About Us
About Epigral
Our Core Ethos
Board of Directors
Our Journey
R&D
Corporate Brochure
Products
Chlor Alkali
Chloromethanes
Hydrogen Peroxide
Epichlorohydrin
CPVC
Chlorotoluenes Value Chain
Product Flow Chart
Sustainability
Certifications
Environment Health and Safety
Corporate Social Responsibility
Investors
Results
Information on Shareholders
Financial Snapshot and Graphs
Shareholding Pattern
Rating Rationale
Governance, Policies & Compliances
FAQs
Key Contacts
Media
Digital Domain
Print Chronicles
Television Broadcasts
Careers
Contact us
Digital Domain
Explore the digital sphere, where we connect and share our narratives, innovations and industry perspectives through online platforms.
Epigral reports Q1 FY26 PAT stood at Rs.160 Cr
3 August 2025
Mr. Maulik Patel discussing future plans of Epigral Limited
24 July 2025
Epigral to expand wind-solar hybrid power plant to 38.14 MW
7 June 2025
Epigral reports Q4 FY25 consolidated PAT at Rs. 86.89 Cr
6 May 2025
Epigral Q4 results: Net profit rises 13% YoY to Rs 87 cr in March quarter
5 May 2025
Epigral Q4 net profit rises 13% to Rs 87 Crore
5 May 2025
Epigral’s CPCV resin and compound receives NSF certification
17 April 2025
Epigral secures NSF certification for CPVC
17 April 2025
Epigral targets 20% annual growth, expects to more than double revenue by FY28
24 February 2025
Epigral Q3 result: PAT more than doubles to Rs 103.63 cr
27 January 2025
Multibagger Stock: Epigral yields 120% return in a year, 430% in over 3 years
18 November 2024
Epigral consolidated net profit rises 114.00% in the September 2024 quarter
9 November 2024
Board of Epigral approves doubling of capacity at Dahej
9 November 2024
Epigral Q2 FY25 PAT up 111% to Rs. 81 Cr
9 November 2024
Eprigral raises Rs. 333 crore via QIP issue
25 October 2024
Chemical manufacturer Epigral Ltd raises Rs 333 crore via QIP issue
25 October 2024
Epigral commissions 35,000 TPA CPVC compound manufacturing plant
29 June 2024
Building a Resilient Brand in the Chemical Industry: The Epigral Story
29 June 2024
Previous
Page
1
Page
2
Page
3
…
Page
6
Next